ECM
ALXN
Everence Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-7,091
| Closed | -$1.3M | – | 781 |
|
2021
Q2 | $1.3M | Hold |
7,091
| – | – | 0.11% | 165 |
|
2021
Q1 | $1.08M | Hold |
7,091
| – | – | 0.1% | 174 |
|
2020
Q4 | $1.11M | Sell |
7,091
-130
| -2% | -$20.3K | 0.11% | 156 |
|
2020
Q3 | $826K | Hold |
7,221
| – | – | 0.09% | 179 |
|
2020
Q2 | $866K | Hold |
7,221
| – | – | 0.1% | 169 |
|
2020
Q1 | $648K | Hold |
7,221
| – | – | 0.09% | 185 |
|
2019
Q4 | $781K | Sell |
7,221
-1,072
| -13% | -$116K | 0.12% | 191 |
|
2019
Q3 | $812K | Hold |
8,293
| – | – | 0.13% | 164 |
|
2019
Q2 | $1.09M | Buy |
8,293
+2,130
| +35% | +$279K | 0.18% | 123 |
|
2019
Q1 | $833K | Buy |
6,163
+1,868
| +43% | +$252K | 0.15% | 149 |
|
2018
Q4 | $418K | Hold |
4,295
| – | – | 0.1% | 230 |
|
2018
Q3 | $597K | Hold |
4,295
| – | – | 0.12% | 199 |
|
2018
Q2 | $533K | Hold |
4,295
| – | – | 0.11% | 213 |
|
2018
Q1 | $479K | Sell |
4,295
-2,540
| -37% | -$283K | 0.11% | 223 |
|
2017
Q4 | $817K | Buy |
6,835
+2,410
| +54% | +$288K | 0.18% | 141 |
|
2017
Q3 | $621K | Hold |
4,425
| – | – | 0.14% | 191 |
|
2017
Q2 | $538K | Hold |
4,425
| – | – | 0.13% | 210 |
|
2017
Q1 | $536K | Hold |
4,425
| – | – | 0.14% | 191 |
|
2016
Q4 | $541K | Hold |
4,425
| – | – | 0.16% | 179 |
|
2016
Q3 | $542K | Hold |
4,425
| – | – | 0.16% | 179 |
|
2016
Q2 | $517K | Hold |
4,425
| – | – | 0.16% | 191 |
|
2016
Q1 | $616K | Hold |
4,425
| – | – | 0.19% | 154 |
|
2015
Q4 | $844K | Hold |
4,425
| – | – | 0.27% | 107 |
|
2015
Q3 | $692K | Hold |
4,425
| – | – | 0.24% | 124 |
|
2015
Q2 | $800K | Hold |
4,425
| – | – | 0.26% | 121 |
|
2015
Q1 | $798K | Hold |
4,425
| – | – | 0.27% | 119 |
|
2014
Q4 | $819K | Hold |
4,425
| – | – | 0.28% | 110 |
|
2014
Q3 | $749K | Hold |
4,425
| – | – | 0.27% | 123 |
|
2014
Q2 | $691K | Hold |
4,425
| – | – | 0.26% | 131 |
|
2014
Q1 | $673K | Hold |
4,425
| – | – | 0.27% | 124 |
|
2013
Q4 | $588K | Hold |
4,425
| – | – | 0.24% | 138 |
|
2013
Q3 | $514K | Hold |
4,425
| – | – | 0.22% | 137 |
|
2013
Q2 | $408K | Buy |
+4,425
| New | +$408K | 0.18% | 155 |
|